Home – Douglas Berger Psychiatrist Tokyo

Douglas Berger psychiatrist Tokyo speaks fluent Japanese and English. Douglas Berger is an American board-certified psychiatrist and Director of the Tokyo Meguro Counseling Center. Dr. Berger received his M.D. and psychiatry training from New York Medical College, and his Ph.D. from the Department of Psychosomatic Medicine at the Tokyo University School of Medicine.

> For more information about Dr. Douglas Berger’s approach to Psychiatry, click here.

> Read honest reviews and make your own decision.

> About Douglas Berger Psychiatrist Tokyo

Use the the intake form to contact Dr. Douglas Berger or by phone: 03-3716-6624 (+81-3-3716-6624 from outside of Japan).

Dr. Gibbons says psychotherapy has evidence: https://t.co/zU0kSJykmp None have double-blinded trials, blind assessments only record unblinded data, and placebo effect is unfilterable with subjective endpoints in unblinded non-inferiority studies. https://t.co/2opApRuwKL #li

The authors own patents on botulinum toxin (BT) for depression/anxiety by facial muscle injection: https://t.co/xMpQbzg2Gy They promote facial injections as the patents are only for these muscles while BT affects the brain injected from many places. https://t.co/tReJReVhnP #li

S Hollon trying to wriggle-out of the need for double blinding and blind placebo control in psychiatric studies with SUBJECTIVE endpoints https://t.co/DkJ7w4TPhN. Quoting Churchill on democracy has nothing to do with treatment of a human condition. See https://t.co/pCdesvYiey

Dr. Byatt makes the point to continue bupropion in this 14wk pregnant patient as she is already exposed for the first trimester: https://t.co/krUSUTsP8t Why Dr. Byatt does not recommend trying to find the lowest effective dose though is baffling. https://t.co/4EE55E1tzZ #li

The open-label GeneSight and unblined/no-blind placebo Genomind studies are at high-risk for researcher bias and should be suspect to extreme caution: https://t.co/y0WTC42zXm Us: https://t.co/f7ZtKavHEq

Load More...

Blue-blocking glasses for mania? https://t.co/vmAOFTUtGb only 11-12 subjects in each group in a single blind (not double-blind) study, only followed for one week. Poorly controlled studies should not have results exaggerated. https://t.co/lABkWI4nXZ

Depression studies have subjective endpoints so that double blind/blind placebo are needed for efficacy: https://t.co/4XySe7dNmt Hope makes all improve on non-inferiority. "Blind assessments" are deceptive as all the subjects and treaters are UNblind. https://t.co/K6iHnNBhQ1

This study https://t.co/1mfQHq3VWs quoted the parents of a 6 year-old who heard their child's voice. They concluded “The voice and image kept him alive" though It could also be a neurological echo of an emotional memory. Psychodynamics are conjecture. https://t.co/RZFx8zOZJO

Genetic tests are expensive: https://t.co/P4nDSdXfE9. Whether “adverse effects” are due to slow metabolism vs. illness are easily studied: crushed Pills can be blindly put in juice. Do this on and off and see which days correspond to symptoms. Us: https://t.co/1HKbrH9Y6i

Pts given 2-mos of CBT-ib (insomnia/bipolar): https://t.co/Gp5qCz4P7h. Dr. Aiken states to give the “expectation..they..deserve a full remission.” But giving expectations to an unblinded cohort w/no placebo control is the exact thing to avoid. https://t.co/UKcXpxJdqE

Load More...